🔎 Trials Near Me

Home › Overweight › Utah

Pag-aaral pangklinika para sa Overweight sa Utah

22 pag-aaral para sa Overweight ang naghahanap ng mga kalahok sa mga site sa Utah.

Mga Lungsod sa Utah

Opisyal na teksto ng pag-aaral (English)

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

  • AMR Clinical, South Jordan
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07837973

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  • Velocity Clinical Research, Salt Lake City, West Jordan
Nagre-recruitPhase 3
Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06672549

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Boeson Research, Provo
  • Velocity Clinical Research - Salt Lake City, West Jordan
Nagre-recruitPhase 3
Edad 45 hanggang 99 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • Ogden Clinic - Canyon View, Ogden
  • Diabetes & Endocrine Treatment Specialists, Sandy City
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07282600

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

  • AMR Clinical, South Jordan
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07353931

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Salt Lake City
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

  • AURORA-1 Clinical Site, Salt Lake City
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743463

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  • George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

  • ACCOMPLISH-2 Research Site, Salt Lake City
Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07654374

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

  • Kalo Clinical Research, West Valley City
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07215559

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

  • Pantheon Clinical Research, Bountiful
  • Alliance for Multispecialty Research Layton Research Center, Layton
  • Chrysalis Clinical Research, LLC, St. George
Nagre-recruitPhase 3
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07684235

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

  • Kailera Clinical Site, Pleasant View
  • Kailera Clinical Site, Salt Lake City
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07284901

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

  • Kailera Clinical Site, Salt Lake City
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07284875

A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy

  • ICON Early Phase Services, LLC, Salt Lake City
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT07654972

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

  • AMR Clinical, Layton
Nagre-recruitPhase 3
Edad 8 hanggang 18 · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT07253285

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

  • Research Site, Salt Lake City
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT07784725

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

  • ACCOMPLISH-1 Research Site, Sandy City
  • ACCOMPLISH-1 Research Site, St. George
Nagre-recruitPhase 3
Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT07654361

Effect of Sleep Extension on Ceramides in People With Overweight and Obesity

  • College of Health Research Complex--University of Utah, Salt Lake City
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 45 · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT06180837

Circadian Intervention to Improve Cardiometabolic Health

  • College of Health Research Complex--University of Utah, Salt Lake City
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 45 · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT05943626

Testing a Tailored Approach to Long-Term Weight Loss Success

  • University of Utah, Salt Lake City
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update May 11, 2026 · NCT07577765

The Acute T-Rex (Timing of Resistance Exercise) Study

  • University of Utah HPER E Buildling, Salt Lake City
Nagre-recruit
Edad 50 hanggang 74 · Lahat ng kasarian · Na-update Abr 3, 2025 · NCT06366399

Mula sa ClinicalTrials.gov, na-kuha noong Set 29, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.